Synopsys INC Form 4 insider transactions
NASDAQ
SNPS
Synopsys INCSynopsys' General Counsel and Corporate Secretary, Janet Lee, sold 250 shares of common stock at $510 per share on January 7, 2026, under a pre-arranged trading plan.
NASDAQ
SNPS
Synopsys INCSynopsys General Counsel Janet Lee reported the vesting of restricted stock units and subsequent tax-related share dispositions on December 31, 2025.
NASDAQ
SNPS
Synopsys INCSynopsys CFO Shelagh Glaser reported the exercise of stock options and subsequent sale of common stock totaling 3,657 shares under a Rule 10b5-1 plan.
NASDAQ
SNPS
Synopsys INCSynopsys Chief Revenue Officer Michael Ellow reported the grant of 6,475 restricted stock units and an update to his indirect common stock holdings.
NASDAQ
SNPS
Synopsys INCSynopsys Inc.'s CFO, Shelagh Glaser, received a grant of 7,554 restricted stock units under the company's 2006 Employee Equity Incentive Plan.
NASDAQ
SNPS
Synopsys INCSynopsys Inc.'s Chief Accounting Officer, Sudhindra Kankanwadi, was granted 4,317 restricted stock units under the company's equity incentive plan.
NASDAQ
SNPS
Synopsys INCSynopsys Inc.'s Executive Chair, Aart de Geus, was granted 2,693 restricted stock units under the company's 2006 equity incentive plan.
NASDAQ
SNPS
Synopsys INCSynopsys, Inc. President and CEO Sassine Ghazi was granted 19,856 restricted stock units under the company's 2006 Employee Equity Incentive Plan.
NASDAQ
SNPS
Synopsys INCSynopsys Inc.'s General Counsel and Corporate Secretary, Janet Lee, was granted 3,238 restricted stock units under the company's 2006 Employee Equity Incentive Plan.
NASDAQ
SNPS
Synopsys INCSynopsys, Inc.'s Chief Revenue Officer, Michael Ellow, was granted 24,286 restricted stock units under the company's 2006 Employee Equity Incentive Plan.
NASDAQ
SNPS
Synopsys INCSynopsys President and CEO Sassine Ghazi reported the vesting of restricted stock units and subsequent share dispositions for tax obligations.
NASDAQ
SNPS
Synopsys INCSynopsys CFO Shelagh Glaser reported the vesting of restricted stock units and subsequent disposition of shares to cover tax obligations on December 8, 2025.
NASDAQ
SNPS
Synopsys INCSynopsys Chief Accounting Officer Sudhindra Kankanwadi reported the vesting of restricted stock units and subsequent tax-related share disposals on December 8, 2025.
NASDAQ
SNPS
Synopsys INCSynopsys Executive Chair Aart de Geus reported the vesting and exercise of restricted stock units and subsequent tax-related share dispositions on December 8, 2025.
NASDAQ
SNPS
Synopsys INCSynopsys GC & Corporate Secretary Janet Lee reported the vesting of restricted stock units and subsequent sale of shares for tax obligations.
NASDAQ
SNPS
Synopsys INCSynopsys General Counsel Janet Lee reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
SNPS
Synopsys INCSynopsys Chief Accounting Officer Sudhindra Kankanwadi exercised stock options and sold shares, realizing over $6.4 million in net proceeds from pre-planned transactions.
NASDAQ
SNPS
Synopsys INCSynopsys Director Robert G. Painter acquired 350 shares of common stock at $425.4397 per share under a pre-arranged trading plan.
NASDAQ
SNPS
Synopsys INCSynopsys Inc. Director Ravi K Vijayaraghavan received automatic equity awards totaling 1,140 shares of common stock under the company's non-employee director plan.
NASDAQ
SNPS
Synopsys INCSynopsys Inc. Director Ajei Gopal was granted 1,140 shares of common stock as automatic awards under the company's equity incentive plan.
NASDAQ
SNPS
Synopsys INCSynopsys Inc. has granted 6,848 restricted stock units to Janet Lee, its General Counsel and Corporate Secretary, as part of its employee equity incentive plan.
NASDAQ
SNPS
Synopsys INCSynopsys CFO Shelagh Glaser executed pre-planned transactions, exercising stock options and selling common stock, as detailed in a recent SEC Form 4 filing.
NASDAQ
SNPS
Synopsys INCSynopsys General Counsel Janet Lee reported the vesting of restricted stock units and the subsequent sale of shares to cover tax obligations.
NASDAQ
SNPS
Synopsys INCSynopsys General Counsel Janet Lee reported the vesting of 700 restricted stock units and the subsequent sale of 305 shares to cover tax obligations.
NASDAQ
SNPS
Synopsys INCSynopsys President and CEO Sassine Ghazi reported the acquisition and sale of company common stock under a pre-arranged 10b5-1 trading plan.
NASDAQ
SNPS
Synopsys INCSynopsys Inc.'s Chief Financial Officer, Shelagh Glaser, acquired 26 shares of common stock through an employee stock purchase plan.
NASDAQ
SNPS
Synopsys INCSynopsys Chief Accounting Officer Sudhindra Kankanwadi acquired 26 shares of common stock through an employee stock purchase plan.
NASDAQ
SNPS
Synopsys INCSynopsys Executive Chair Aart de Geus acquired 26 shares of common stock through an employee stock purchase plan.
NASDAQ
SNPS
Synopsys INCSynopsys Chief Revenue Officer Richard S. Mahoney acquired 26 shares of common stock through the company's Employee Stock Purchase Plan.
NASDAQ
SNPS
Synopsys INCSynopsys Director Ajei Gopal's unvested restricted stock units accelerated and vested upon his employment termination, leading to significant common stock transactions.